Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 153 EP applications Adrian Hugh Brasnett has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11785541

VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS

IPC classification:
C12N 15/62, C07K 14/44, A61K 39/008
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11790705

TREATMENT OF CANCER WITH ELEVATED DOSAGES OF SOLUBLE FGFR1 FUSION PROTEINS

IPC classification:
A61P 35/00, A61K 38/17
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11784918

FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES

IPC classification:
C07K 19/00, A61K 38/17, A61K 33/24, A61K 31/7048, A61K 31/704, A61K 31/555, A61K 31/513, A61K 31/4745, A61K 39/395, A61P 35/00, A61K 45/06, A61K 38/18, A61K 31/519, A61K 31/475, A61K 31/337
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12737028

SOMATIC CELLS WITH INNATE POTENTIAL FOR PLURIPOTENCY

IPC classification:
C12N 5/071
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP12713848

IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR INDUCING HUMORAL AND CELLULAR IMMUNE RESPONSES

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12708189

OLEFINS AND METHODS FOR MAKING THE SAME

IPC classification:
C07C 5/05
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12706967

BASE OILS AND METHODS FOR MAKING THE SAME

IPC classification:
C10M 177/00, C07C 5/03, C07C 2/58
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12720058

METHODS FOR GENOMIC MODIFICATION

IPC classification:
C12N 15/90, C12N 15/81
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12723327

METHODS AND COMPOSITIONS FOR DETECTING MICROBIAL PRODUCTION OF WATER-IMMISCIBLE COMPOUNDS

IPC classification:
G01N 33/58, C12P 5/00
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11841347

METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII

IPC classification:
C07K 14/71, A61K 38/00, A61K 39/00, A61K 38/18, C12N 15/00, C12P 21/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP11835168

BODY FLUID BIN1 AS A MARKER OF CARDIAC HEALTH

IPC classification:
G01N 33/68, C07K 14/435, G01N 33/50
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP12797060

MACROMOLECULES

IPC classification:
A61K 47/48, A61K 47/34, A61K 39/00, A61K 38/00, A61K 31/00, C08G 73/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12743036

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CELIAC DISEASE AND GLUTEN INTOLERANCE

IPC classification:
A61K 38/48, A61K 9/00, G01N 33/53, A61P 39/00, A61P 37/00, A61P 1/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13172042

Vaccine composition containing synthetic adjuvant

IPC classification:
A61P 37/00, A61K 39/145, A61K 39/04, A61K 39/008, A61K 31/7028
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12710838

COMBINATION THERAPIES FOR HEMATOLOGIC MALIGNANCIES

IPC classification:
A61K 45/06, A61K 39/00, A61K 31/52, A61K 31/4439, A61K 31/4184, A61P 35/02, A61P 35/00
Applicant:
Gilead Calistoga LLC
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12714910

METHODS AND COMPOSITIONS FOR NORMALIZATION OF TUMOR VASCULATURE BY INHIBITION OF LOXL2

IPC classification:
A61K 31/7088, C07K 16/40
Applicant:
Gilead Biologics, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12827654

METHODS FOR GENERATING CARDIOMYOCYTES

IPC classification:
A01N 65/00, A01N 63/00, C12N 5/02, C12N 5/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12826796

ENGINEERED SEQUENCES TO FACILITATE EXPRESSION OF ANTIGENS IN NEISSERIA AND METHODS OF USE

IPC classification:
A61K 39/095
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12831844

DETECTION OF VIRAL INFECTION

IPC classification:
C12Q 1/70, C12Q 1/68
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13172134

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis

IPC classification:
A61K 39/116, A61K 39/095, A61K 39/02, A61K 39/00, A61K 38/00, C07K 1/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14164800

Nucleic acids, compositions and methods for the excision of target nucleic acids

IPC classification:
C12N 15/81
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12838704

METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTION

IPC classification:
A61K 31/7088, C12N 15/55
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14158177

Method and composition for crystallizing G protein-coupled receptors

IPC classification:
C12P 21/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13194273

Non-integrating lentiviral vectors

IPC classification:
A61K 39/00, C12N 15/867
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12845201

REPROGRAMMING OF CELLULAR ADHESION

IPC classification:
A61K 9/127
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13154049

Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use

IPC classification:
A61K 39/095, C07K 16/12
Applicant:
Novartis Vaccines and Diagnostics Srl
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12795948

PRODUCTION OF ACETYL-COENZYME A DERIVED ISOPRENOIDS

IPC classification:
C12P 23/00, C12P 5/00, C12N 15/52
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12849489

METHODS OF TREATING CANCER

IPC classification:
A61K 39/00, C12P 21/08, C07K 1/00, C07H 21/04
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12850371

MODIFIED DNA-BINDING PROTEINS AND USES THEREOF

IPC classification:
C12N 15/87, C07K 14/195
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12850580

COLLAGEN-LIKE SILK GENES

IPC classification:
A61K 47/42, C12N 15/63, C07K 14/435
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11865925

METHOD OF TREATMENT OR PROPHYLAXIS OF BACTERIAL VAGINOSIS

IPC classification:
A61K 38/16, A61K 31/795, A61K 9/00, A61P 15/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12862964

COMPOSITIONS AND METHODS FOR REGULATING GLUCOSE METABOLISM

IPC classification:
A61K 38/00, C07K 14/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13793997

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

IPC classification:
C12N 15/63, C12N 15/11, C12N 5/10, C07K 19/00
Applicant:
Helmholtz Centre for Infection Research - Department Regulation in Infection Biology
Applicant:
University of California
Applicant:
University of Vienna (Universität Wien)
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12815166

TARGETING GLI PROTEINS IN HUMAN CANCER BY SMALL MOLECULES

IPC classification:
A61K 31/4155, A61K 31/415, C07D 409/04, C07D 231/06, A61P 35/00
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12786378

ANTI-PROLIFERATIVE COMPOUNDS AND METHODS FOR USING THE SAME

IPC classification:
A61K 31/4406, A61K 31/421, A01N 43/40, C07D 413/04
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12782714

PRODUCTION OF ACETYL-COENZYME A DERIVED COMPOUNDS

IPC classification:
C12P 5/02
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13746983

IMPROVED ADJUVANT FORMULATIONS COMPRISING TLR4 AGONISTS AND METHODS OF USING THE SAME

IPC classification:
A61K 9/107
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13749899

DIMETHYLARGININE DIMETHYLAMINOHYDROLASE INHIBITORS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/4188, A61K 31/4184
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13765207

NON-HUMAN ANIMAL MODELS OF DEPRESSION AND METHODS OF USE THEREOF

IPC classification:
A01K 67/027, A61N 5/06, A61N 1/30
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13716670

LENTIVIRAL VECTOR PARTICLES HAVING IMPROVED TRANSDUCTION EFFICIENCY FOR CELLS EXPRESSING DC- SIGN

IPC classification:
A61K 39/00, C12N 15/867, C07K 14/18, C07K 14/16
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13770214

COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS

IPC classification:
A61K 38/24, A61K 38/18, A61K 38/00, C12P 21/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13770325

COMPOSITIONS AND METHODS FOR REACTIVATING LATENT IMMUNODEFICIENCY VIRUS

IPC classification:
A61K 31/551
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13772583

HERBICIDAL COMPOUND SCREENING

IPC classification:
A01H 1/00
Agent:
Andrew John Thompson, Withers & Rogers LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12858028

COMPOSITIONS AND METHODS FOR INHIBITING IMMUNODEFICIENCY VIRUS TRANSCRIPTION

IPC classification:
A61K 45/06, A61K 38/16, A61K 31/7072, A61K 31/675, A61K 31/603, A61K 31/551, A61K 31/513, A61K 31/47, A61K 31/46, A61K 31/225, A61K 31/192, A01N 37/10, A61P 31/18
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13751108

COMPOSITIONS AND METHODS FOR TREATING NEUROGENIC DISORDERS OF THE PELVIC FLOOR

IPC classification:
A61P 21/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13760878

METHODS AND COMPOSITIONS FOR TREATING WOUNDS AND REDUCING THE RISK OF INCISIONAL HERNIAS

IPC classification:
A61K 38/00, A61P 17/02
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP13779097

COMPOSITIONS AND METHODS FOR DETECTING UNSTABLE ARTERIOSCLEROTIC PLAQUES

IPC classification:
G01N 33/68, G01N 33/573, G01N 33/50
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13777529

METHODS AND SYSTEMS FOR DETECTING AN ANALYTE OR CLASSIFYING A SAMPLE

IPC classification:
G01N 33/53, G01N 21/76, C12Q 1/66
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13777737

CELL TRANSFECTION METHOD

IPC classification:
A01K 67/027, A01K 67/02, C12N 15/90, C12N 15/89, C12N 15/88, C12N 15/873, C12N 15/85, C12N 5/16
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13782495

HIGH OLEIC ACID OILS

IPC classification:
A23D 9/00, A01H 5/10, C12N 15/53, C12N 15/29, C12N 15/113, C12N 9/02, C11B 1/10
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13788413

METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION OF TRANSGENES

IPC classification:
C12N 15/87, C12N 15/00, C12N 5/10
Applicant:
Sangamo BioSciences, Inc.
Applicant:
Dow AgroSciences LLC
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12722048

METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)

IPC classification:
C07K 16/28, A61P 37/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13724492

VACCINES FOR HSV-2

IPC classification:
A61K 38/00, G01N 33/569, C07K 14/005
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13770285

SILK POLYPEPTIDES

IPC classification:
A61K 38/17, C12N 15/12, C07K 14/435
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14191235

Cell line, system and method for optical control of secondary messengers

IPC classification:
C12P 21/06, C12P 21/04
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13799826

COMPOSTIONS AND METHODS FOR CANCER IMMUNOTHERAPY

IPC classification:
A61P 37/04
Applicant:
Johns Hopkins University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP13798071

METHOD OF TREATING SCEDOSPORIUM SPP. INFECTION

IPC classification:
A61K 31/4184, A61K 31/36, A61P 31/10
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13820140

ANTIBODY SPECIFIC FOR CD22 AND METHODS OF USE THEREOF

IPC classification:
A61K 39/00
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13836324

COMPOSITIONS AND METHODS FOR TREATING AN ACTIVE MYCOBACTERIUM TUBERCULOSIS INFECTION

IPC classification:
A61K 39/04
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12739749

METHODS FOR GENERATING INNER EAR CELLS IN VITRO

IPC classification:
G01N 33/50, C12N 5/079, A61P 27/16, A61K 35/30
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12197200

Methods and compositions for determining a graft tolerant phenotype in a subject

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP11838856

CONTROL AND CHARACTERIZATION OF MEMORY FUNCTION

IPC classification:
A61K 38/17
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP13833614

METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)

IPC classification:
A61K 39/395, G01N 33/564, C12Q 1/48, C07K 16/28, A61P 29/00, A61P 19/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13837849

METHOD OF TREATMENT OR PROPHYLAXIS OF INFECTIONS OF THE EYE

IPC classification:
A61K 31/255, A61K 31/198, A61P 27/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP12706395

METHODS FOR ENHANCING IMMUNOGEN SPECIFIC IMMUNE RESPONSES BY VECTORED VACCINES

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15161439

IMPROVED YIELD AND STRESS TOLERANCE IN TRANSGENIC PLANTS

IPC classification:
A01H 5/00, A01H 1/00, C12N 15/82, C12N 5/04
Applicant:
Monsanto Company
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13853070

FACULTATIVELY ATTENUATED BACTERIAL SPECIES AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61K 35/74
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13856783

IMMUNOMODULATORY PEPTIDES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/395, A61K 39/39, C12N 5/07, C07K 14/715, C07K 14/555, C07K 7/08, A61P 37/04, A61P 31/12
Applicant:
University of Alberta
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13859888

METHODS AND COMPOSITIONS FOR REGULATION OF METABOLIC DISORDERS

IPC classification:
C12N 5/10
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13862361

METHODS FOR HIGH THROUGHPUT RECEPTOR:LIGAND IDENTIFICATION

IPC classification:
C40B 30/06
Applicant:
Albert Einstein College of Medicine Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15168694

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

IPC classification:
A61K 48/00, A61K 31/712, A61K 31/7088, C12N 15/113, C07H 21/00
Applicant:
University of Western Australia
Agent:
D Young & Co LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13863379

COMPOSITIONS COMPRISING CYCLIC PURINE DINUCLEOTIDES HAVING DEFINED STEREOCHEMISTRIES AND METHODS FOR THEIR PREPARATION AND USE

IPC classification:
C07H 21/00, A61P 37/04, A61P 37/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13862780

MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY

IPC classification:
A61K 31/00, C07K 16/40, C07K 16/28, C07K 16/18, C07K 14/47
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP13869448

SIGNAL PEPTIDE FUSION PARTNERS FACILITATING LISTERIAL EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61K 39/00, C12N 15/74, C07K 14/195
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14740804

GROWTH FACTOR SEQUESTERING AND PRESENTING HYDROGELS

IPC classification:
C12N 11/04, C12N 5/02
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14743956

TARGETING GLI PROTEINS IN HUMAN CANCER BY SMALL MOLECULES

IPC classification:
A61K 31/415
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14743049

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CELIAC DISEASE AND GLUTEN INTOLERANCE

IPC classification:
A61K 38/48, A61K 38/46, A61K 38/43
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14704239

PHARMACEUTICAL FORMULATION COMPRISING AN INSOLUBLE CORTICOSTEROID AND A SOLUBLE CORTICOSTEROID

IPC classification:
A61K 47/36, A61K 31/573
Agent:
Cooley (UK) LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13874703

ENDOPHYTIC MICROBIAL SYMBIONTS IN PLANT PRENATAL CARE

IPC classification:
C12N 15/00, C12N 1/14, B09C 1/10, A01P 3/00, A01P 21/00, A01N 63/04, A01N 63/02, A01H 5/10, A01H 17/00, C12N 1/20
Applicant:
University of Saskatchewan Industry Liaison Office
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14751227

CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF

IPC classification:
C12N 5/0783, C07K 16/28, C07K 14/705, A61K 48/00
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP14751523

COMPOSITIONS AND METHODS OF USE THEREOF FOR IDENTIFYING ANTI-VIRAL AGENTS

IPC classification:
C12Q 1/70
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14756984

GENERATION OF THYMIC EPITHELIAL PROGENITOR CELLS IN VITRO

IPC classification:
C12N 5/02
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14753924

METHODS AND COMPOSITIONS FOR ENHANCING NUCLEASE-MEDIATED GENE DISRUPTION

IPC classification:
C12N 9/16
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15177471

METHOD OF TARGETED GENE DELIVERY USING VIRAL VECTORS

IPC classification:
A61K 39/00, C07K 16/28, C12N 15/86
Applicant:
California Institute of Technology
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP14779898

METHODS AND COMPOSITIONS FOR MODIFICATION OF HLA

IPC classification:
C12N 5/0783, C12N 5/02, C12N 5/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14770952

COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION

IPC classification:
C12N 15/113, A61P 31/18
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14773609

FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOF

IPC classification:
C07K 16/28
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14768321

PURIFICATION OF TRIPLE HELICAL PROTEINS

IPC classification:
C07K 1/30, C07K 1/14
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14779659

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY

IPC classification:
A61P 31/12
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14731420

GLA MONOTHERAPY FOR USE IN CANCER TREATMENT

IPC classification:
A61P 35/00, A61K 31/7028
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14784959

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
C07K 14/54, A61P 31/04, A61K 38/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14785742

G PROTEIN COUPLED RECEPTOR LIBRARIES

IPC classification:
C12N 15/81, G01N 33/22, G01N 33/566, C40B 40/02, C07K 14/705, C12Q 1/02
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14794007

ENRICHMENT OF DNA SEQUENCING LIBRARIES FROM SAMPLES CONTAINING SMALL AMOUNTS OF TARGET DNA

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14778308

METHODS OF TREATING DISEASES CHARACTERIZED BY EXCESSIVE WNT SIGNALLING

IPC classification:
A61P 35/00, A61K 39/395, A61K 31/7088, A61K 31/519, A61K 31/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14884476

E1E2 HCV VACCINES AND METHODS OF USE

IPC classification:
A61P 31/14, A61K 39/29
Applicant:
University of Alberta
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12705186

GEL-ENCAPSULATED MICROCOLONY SCREENING

IPC classification:
C12P 5/00, G01N 33/50, C12Q 1/02
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14806809

COMPOSITIONS AND METHODS FOR REDUCING OR PREVENTING METASTASIS

IPC classification:
A61K 39/39
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15191395

MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY

IPC classification:
A61K 47/48, A61K 38/16, C07K 19/00, C07K 14/21, C07K 14/195
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP15191391

MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY

IPC classification:
A61K 47/48, A61K 38/16, C07K 19/00, C07K 14/21, C07K 14/195
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP15191388

MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY

IPC classification:
A61K 47/48, A61K 38/16, C07K 19/00, C07K 14/21, C07K 14/195
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14810750

TRANSAMINASE BIOCATALYSTS

IPC classification:
C12P 13/00, C12N 15/54, C12N 9/10, C07K 14/21, C12P 7/44
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11811474

WHOLE BLOOD ASSAY FOR MEASURING AMPK ACTIVATION

IPC classification:
C12N 9/12, G01N 33/50
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14748326

SEED-ORIGIN ENDOPHYTE POPULATIONS, COMPOSITIONS, AND METHODS OF USE

IPC classification:
A01C 1/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14803589

ADENO-ASSOCIATED VIRUS VARIANTS AND METHODS OF USE THEREOF

IPC classification:
C12N 7/00, A61K 35/76, A61K 48/00
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15196123

PRODUCTION OF ISOPRENOIDS AND ISOPRENOID PRECURSORS

IPC classification:
C12N 9/88, C12N 9/12, C12N 1/00
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11838859

UPCONVERSION OF LIGHT FOR USE IN OPTOGENETIC METHODS

IPC classification:
B82Y 5/00, A61K 48/00, A61K 41/00, A61N 5/06, A61M 37/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14752705

AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES

IPC classification:
A61P 35/00, A61K 39/00, C07K 16/28
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14831454

NON-NATURALLY OCCURRING FACTOR H BINDING PROTEINS (FHBP) AND METHODS OF USE THEREOF

IPC classification:
A61K 39/095
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15190341

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

IPC classification:
C07H 21/00, A61K 31/712, A61K 31/7088, A61K 48/00, C12N 15/113
Applicant:
University of Western Australia
Agent:
D Young & Co LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13748255

METHODS FOR STABILIZING PRODUCTION OF ACETYL-COENZYME A DERIVED COMPOUNDS

IPC classification:
C12P 5/00, C12N 1/16, C12N 15/81
Applicant:
Amyris, Inc.
Applicant:
TOTAL MARKETING SERVICES
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15200471

PRODUCTION OF ISOPRENOIDS

IPC classification:
C12P 7/04, C12P 7/02, C12P 7/00, C12N 15/52, C12P 5/00
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14836465

COMPOSITIONS AND METHODS FOR CONTROLLING PAIN

IPC classification:
C12N 15/864
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14840710

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/20
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14843092

VACCINE COMPOSITIONS FOR DRUG ADDICTION

IPC classification:
C07K 17/02, A61K 39/00, A61K 31/7028
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14777213

AGRICULTURAL ENDOPHYTE-PLANT COMPOSITIONS, AND METHODS OF USE

IPC classification:
A01C 1/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14842530

MODIFIED BACTERIAL COLLAGEN-LIKE PROTEINS

IPC classification:
C12N 15/31, C12P 21/02, A61K 8/65, A61K 38/16, C07K 14/78
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14853797

DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING IN HEMATOPOIETIC STEM CELLS

IPC classification:
C07H 21/04, C12P 21/04, C12N 15/87, C12N 15/00, C12N 5/00, A01N 63/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14860187

FUNGAL ENDOPHYTES FOR IMPROVED CROP YIELDS AND PROTECTION FROM PESTS

IPC classification:
A01N 65/00, A01N 63/00, A01H 5/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14860137

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14866453

METHOD OF DETECTING PLASMODIUM INFECTION

IPC classification:
C12Q 1/04, G01N 33/497, G01N 33/48
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11838862

OPTOGENETIC CONTROL OF REWARD-RELATED BEHAVIORS

IPC classification:
G01N 33/50, A01K 67/027
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12742056

METHODS OF DEVELOPING TERPENE SYNTHASE VARIANTS

IPC classification:
C12Q 1/527, C12N 9/88
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14869305

METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA

IPC classification:
C07K 14/00
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14869259

METHODS AND COMPOSITIONS FOR MODIFYING A SINGLE STRANDED TARGET NUCLEIC ACID

IPC classification:
C12N 9/96
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16167704

ENDORIBONUCLEASE COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
G01N 33/573, C12Q 1/34, C12N 15/55, C12N 9/22, C12Q 1/68
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP14876108

CAS9 CRYSTALS AND METHODS OF USE THEREOF

IPC classification:
C12N 9/00, C12P 19/34, C07K 14/315
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15735215

IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61P 37/04, A61K 39/00, A61K 39/39
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15703170

COMPOSITIONS FOR USE IN THE TREATMENT OF ALLERGIC CONDITIONS

IPC classification:
A61P 37/08, A61K 31/7024
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15748477

PARTITIONING OF DNA SEQUENCING LIBRARIES INTO HOST AND MICROBIAL COMPONENTS

IPC classification:
C12Q 1/68, C12Q 1/00
Agent:
De Clercq & Partners cvba
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15709383

IMMUNOTHERAPY OF CANCER THROUGH COMBINATION OF LOCAL AND SYSTEMIC IMMUNE STIMULATION

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15748774

METHOD OF DETECTING CANCER

IPC classification:
G01N 33/574
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15752803

METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION

IPC classification:
C12N 5/10, C12N 15/64, A61K 48/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15777221

METHODS AND COMPOSITIONS FOR USING ARGONAUTE TO MODIFY A SINGLE STRANDED TARGET NUCLEIC ACID

IPC classification:
C07K 14/195, C12P 19/34, C12N 15/63
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15723609

SOLVENT COMPOSITIONS BASED ON DIHYDROFARNESENE

IPC classification:
C11D 7/50, C11D 3/18, A61Q 19/00, A61Q 5/06, A61Q 1/04, A61K 8/31
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15786844

INHIBITORS OF JMJD2C AS ANTICANCER AGENTS

IPC classification:
C07D 215/24, A61K 31/4709
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP15789214

METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE

IPC classification:
C07H 21/04, A61K 38/54, A61K 38/00, A61K 38/16, A61K 48/00
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15803224

COMPOSITIONS AND METHODS FOR TARGETING A PATHWAY

IPC classification:
C12P 21/08, C07K 16/00, C07K 17/00, C07K 14/00, C07K 1/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15745647

PRIME-BOOST REGIMENS WITH A TLR4 AGONIST ADJUVANT AND A LENTIVIRAL VECTOR

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16189132

SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS

IPC classification:
A61K 31/713, C07K 14/47
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP15838726

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION

IPC classification:
C07H 21/02, C12P 19/34, A61K 48/00
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP16197498

DEVICES FOR OPTICAL STIMULATION OF TARGET CELLS USING AN OPTICAL TRANSMISSION ELEMENT

IPC classification:
A61N 5/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP15747902

METHODS FOR PREPARING PLATELET PRODUCTS

IPC classification:
A61K 35/19, C12N 5/078
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP15848341

TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN

IPC classification:
C07H 21/04, C12N 15/00, C12N 5/02, C12N 15/11, A61K 48/00
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP17152598

COMPOSITIONS FOR TREATING NEUROGENIC DISORDERS OF THE PELVIC FLOOR

IPC classification:
C12N 15/864, A61K 48/00, A61P 21/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The application has been published
EP15848940

COMPOSITIONS AND METHODS FOR TREATING VIRAL HEMORRHAGIC FEVER

IPC classification:
A61K 35/16, C07K 16/34
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP15790387

SLAMF1 ANTAGONISTS AND USES THEREOF

IPC classification:
C07K 16/28
Agent:
Murgitroyd & Company
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
Request for examination was made
EP15798264

COMBINATION THERAPY FOR CANCER

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/28
Applicant:
Bristol-Myers Squibb Company
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP15860271

METALLOPROTEIN COMPOSITIONS

IPC classification:
G01N 31/10, C12Q 1/25, D01F 4/02, C07K 14/795
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP17156198

OPTOGENETIC CONTROL OF REWARD-RELATED BEHAVIORS

IPC classification:
G01N 33/50, A01K 67/027
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The application has been published
EP17164599

POLYNUCLEOTIDES AND POLYPEPTIDES IN PLANTS

IPC classification:
A01H 5/00, C12N 15/82, C12N 15/29
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Examination is in progress
EP17163093

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

IPC classification:
A61P 37/00, A61K 39/145, A61K 39/04, A61K 39/008, A61K 31/7028
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The application has been published
EP17168534

ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF

IPC classification:
G01N 33/50, C12N 15/115, C12N 15/113, C12Q 1/70, C12N 7/00, A61K 9/00, A61K 38/17, C12N 15/86, C07K 14/005, C12N 15/63, A61K 48/00
Applicant:
University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP17162270

METHOD FOR REDUCING DEHYDRATION IN A RED BLOOD CELL COMPOSITION

IPC classification:
A61K 35/18, A61P 7/00, A61L 2/00, A01N 43/42, A01N 1/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature